Bromocriptin Mesylate Tablets IP 2.5 mg Manufacturer in India – Healthy Life Pharma Pvt. Ltd.

Bromocriptin Mesylate Tablets IP 2.5 mg | Manufacturer
Product image for Bromocriptin Mesylate Tablets IP 2.5 mg Manufacturer; contract manufacturing, oem & quality control.
Product Information
| Generic Name | Bromocriptin Mesylate |
|---|---|
| Manufacturer | Healthy Life Pharma Pvt. Ltd. |
| HSN Code | 30049099 |
| Pharmacopoeia | IP |
| Product Type | Tablet |
| Category | Antiparkinsonian drugs |
| Subcategory | Antiparkinsonian drugs |
| Active Ingredient | Bromocriptin Mesylate |
| Strength | 2.5 mg |
| Dosage Form | Tablet |
| Pack Size | 10 x 10 Tablets / Box (Alu-Alu / Blister) |
| Route of Administration | Oral |
| Prescription Required | Yes |
| Therapeutic Category | Antiparkinsonian drugs |
Medicine Details & Safety
| Short Description | Healthy Life Pharma invites contract and third-party manufacturing enquiries for Bromocriptin Mesylate Tablets IP 2.5 mg from pharmaceutical marketing companies, institutional buyers and brand owners. Production specifications, batch size and packaging are agreed against the approved product dossier and purchase requirements. | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Approved Uses / Indications | 1. Management of generalized tonic-clonic, focal, and absence epileptic seizures. 2. Adjunctive treatment in trigeminal neuralgia, neuropathic pain, and mood stabilization. | ||||||||||||||||||||||||
| Full Description | Healthy Life Pharma invites contract and third-party manufacturing enquiries for Bromocriptin Mesylate Tablets IP 2.5 mg from pharmaceutical marketing companies, institutional buyers and brand owners. Production specifications, batch size and packaging are agreed against the approved product dossier and purchase requirements. Product technical specifications
Product technical specifications
Manufacturing capabilities and infrastructureFor Bromocriptin Mesylate Tablets IP 2.5 mg, assess the approved formulation process, equipment suitability, batch scale and in-process controls for the Tablet presentation. Confirm environmental requirements and validated process before production.Quality control and assuranceRequest the approved finished-product specification for Bromocriptin Mesylate Tablets IP 2.5 mg, including applicable identity, assay, uniformity and performance tests for the Tablet presentation. Confirm analytical methods, acceptance criteria and batch release documentation, including COA availability.Primary and secondary packagingThe catalogue pack for Bromocriptin Mesylate Tablets IP 2.5 mg is 10 x 10 Tablets / Box (Alu-Alu / Blister). Confirm primary packaging compatibility, stability evidence, artwork, batch coding and leaflet requirements against the approved specification.Contract manufacturing and private labelSubmit the target market, strength, pharmacopoeial specification, forecast volume and brand artwork. Agree feasibility, batch size, quality agreement, production schedule and release criteria before execution. | ||||||||||||||||||||||||
| Dosage Instructions | Administer orally at regular scheduled intervals daily. Swallow whole with water; maintain consistent dosing to achieve stable therapeutic anticonvulsant plasma concentrations. | ||||||||||||||||||||||||
| Side Effects | Common: Drowsiness, fatigue, ataxia, dizziness, diplopia, nausea. Uncommon: Tremor, cognitive slowing, skin rash, mild transaminase elevation. Rare: Stevens-Johnson syndrome, hepatotoxicity, pancreatitis, aplastic anemia. | ||||||||||||||||||||||||
| Warnings and Precautions | Abrupt Discontinuation: Never stop abruptly; gradual withdrawal over weeks is required to avoid precipitating status epilepticus. Suicidal Ideation: Monitor closely for emergence of depressive mood changes or suicidal thoughts. Hepatic & Hematologic Testing: Regular blood counts and liver enzymes are recommended. | ||||||||||||||||||||||||
| Contraindications | 1. Known hypersensitivity to Bromocriptin Mesylate or related anticonvulsant chemical structures. 2. Acute intermittent porphyria or atrioventricular conduction block. 3. Severe hepatic impairment or preexisting bone marrow depression. | ||||||||||||||||||||||||
| Drug Interactions | 1. Other Antiepileptics (Phenytoin, Carbamazepine, Valproate): Mutual metabolic induction or inhibition requiring serum monitoring. 2. Oral Contraceptives: Enzyme-inducing anticonvulsants decrease contraceptive hormone efficacy. 3. CNS Depressants & Alcohol: Marked intensification of central nervous system depression. |
Frequently Asked Questions
| Question | Answer |
|---|---|
| Can I request third-party manufacturing for Bromocriptin Mesylate Tablets IP 2.5 mg? | Submit your brand, quantity and packaging requirements for manufacturing feasibility review. |
| Which pharmacopoeial standard applies for Bromocriptin Mesylate Tablets IP 2.5 mg? | The source specification is IP; confirm the required standard before contracting. |
| What quality tests are applicable for Bromocriptin Mesylate Tablets IP 2.5 mg? | Request the approved finished-product specification and batch testing plan. |
| Can packaging be customized for Bromocriptin Mesylate Tablets IP 2.5 mg? | Submit artwork and pack requirements for technical and regulatory review. |
| How do I request a manufacturing quotation for Bromocriptin Mesylate Tablets IP 2.5 mg? | Provide forecast volume, target market, strength and packaging requirements. |
Related Products
✚
Bromocriptin Mesylate Tablets IP 2.5 mg ExporterView product →
✚
Bromocriptin Mesylate Tablets IP 2.5 mg SupplierView product →
✚
Benzhexol Hydrochloride Tablets IP 5 mg ExporterView product →
✚
Benzhexol Hydrochloride Tablets IP 5 mg ManufacturerView product →
✚
Benzhexol Hydrochloride Tablets IP 5 mg SupplierView product →
✚
Benzhexol Tablets BP 2 mg ExporterView product →
✚
Benzhexol Tablets BP 2 mg ManufacturerView product →
✚
Benzhexol Tablets BP 2 mg SupplierView product →
✚
Benzhexol Tablets BP 5 mg ExporterView product →
✚
Benzhexol Tablets BP 5 mg ManufacturerView product →
✚
Benzhexol Tablets BP 5 mg SupplierView product →
✚
Benzhexol Tablets IP 2 mg ExporterView product →
Latest Posts
✚
WHO GMP certfied Glibenclamide Metformin SR TabletsRead article →✚
WHO GMP certfied Frusemide Tablets ManufacturerRead article →✚
Folic Acid Niacinamide Tablets ManufacturerRead article →✚
WHO GMP certfied Folic Acid Tablets ManufacturerRead article →✚
WHO GMP certfied Fluconazole Tablets ManufacturerRead article →✚
WHO GMP certfied Ferrous Sulphate with folic acid TabletsRead article →✚
WHO GMP certfied iron with folic acid Tablets ManufacturerRead article →✚
WHO GMP certfied Ferrous Sulphate Tablets ManufacturerRead article →